Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Non-cash Items (2016 - 2018)

Vanda Pharmaceuticals (VNDA) has disclosed Non-cash Items for 10 consecutive years, with $3.3 million as the latest value for Q1 2018.

  • Quarterly Non-cash Items fell 84.61% to $3.3 million in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Mar 2018, down 84.61% year-over-year, with the annual reading at $24.4 million for FY2017, 24.75% down from the prior year.
  • Non-cash Items hit $3.3 million in Q1 2018 for Vanda Pharmaceuticals, down from $24.4 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $37.4 million in Q3 2017 to a low of $198148.0 in Q2 2015.
  • Historically, Non-cash Items has averaged $14.4 million across 5 years, with a median of $11.8 million in 2016.
  • Biggest five-year swings in Non-cash Items: crashed 94.31% in 2015 and later surged 5855.14% in 2016.
  • Year by year, Non-cash Items stood at $28.5 million in 2014, then plummeted by 73.71% to $7.5 million in 2015, then soared by 332.82% to $32.5 million in 2016, then decreased by 24.75% to $24.4 million in 2017, then plummeted by 86.39% to $3.3 million in 2018.
  • Business Quant data shows Non-cash Items for VNDA at $3.3 million in Q1 2018, $24.4 million in Q4 2017, and $37.4 million in Q3 2017.